CMS Measure ID:CMS645v1
Version:1
NQF Number:None
Measure Description:Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT.
Initial Patient Population:Male patients with a diagnosis of prostate cancer and an order for or who are actively undergoing ADT for a period greater than or equal to 12 months with an office visit during the measurement period
Denominator Statement:Equals Initial Population
Denominator Exclusions:None
Numerator Statement:Patients with a bone density evaluation within the two years prior to the start of or less than three months after the start of ADT treatment
Numerator Exclusions:None
Denominator Exceptions:Patient refused recommendation for a bone density evaluation after the start of ADT therapy